GB1145623A - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- GB1145623A GB1145623A GB1037666A GB1037666A GB1145623A GB 1145623 A GB1145623 A GB 1145623A GB 1037666 A GB1037666 A GB 1037666A GB 1037666 A GB1037666 A GB 1037666A GB 1145623 A GB1145623 A GB 1145623A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acceptable salt
- physiologically acceptable
- compositions
- march
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
1,145,623. Pharmaceutical compositions. E. C. BARTON-WRIGHT. 9 March, 1967 [9 March, 1966], No. 10376/66. Heading A5B. A pharmaceutical composition for the treatment of osteo- and rheumatoid-arthritis consists essentially of the active ingredients dpantothenic acid or a physiologically acceptable salt thereof e.g. the Na or Ca salts, and cysteine or cystine (or a physiologically acceptable salt of either, e.g. the hydrochloride). Modified compositions may also contain queen bee substance ("royal jelly"), ethyl n-heptyloxyacetate or 10-hydroxy-#<SP>2</SP>-decenoic acid or a physiologically acceptable salt thereof. The compositions may be administered orally in the form of tablets, capsules or dragees which may be enteric coated, parenterally from dry ampoules and from ampoules and multidose flasks containing pyrogen-free water, aqueous polyvinylpyrrolidone or arachis oil as a carrier, and rectally as suppositories.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1037666A GB1145623A (en) | 1966-03-09 | 1966-03-09 | Pharmaceutical composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1037666A GB1145623A (en) | 1966-03-09 | 1966-03-09 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1145623A true GB1145623A (en) | 1969-03-19 |
Family
ID=9966712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1037666A Expired GB1145623A (en) | 1966-03-09 | 1966-03-09 | Pharmaceutical composition |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1145623A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2198942A (en) * | 1985-11-27 | 1988-06-29 | Senju Pharma Co | Therapeutic composition for diabetic complications |
US5364885A (en) * | 1992-11-13 | 1994-11-15 | Ahluwalia Gurpreet S | Reduction of hair growth |
WO2001019359A2 (en) * | 1999-09-16 | 2001-03-22 | Britannia Pharmaceuticals Limited | Medicaments containing pantothenic acid for the treatment of inflammatory joint disease |
US8906966B2 (en) | 2006-07-13 | 2014-12-09 | Paul Sherwood | Medicaments containing panthenol |
US10004711B2 (en) | 2014-05-08 | 2018-06-26 | Dsm Ip Assets B.V. | Methods and compositions comprising 10-hydroxy-2-decenoic acid |
-
1966
- 1966-03-09 GB GB1037666A patent/GB1145623A/en not_active Expired
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2198942A (en) * | 1985-11-27 | 1988-06-29 | Senju Pharma Co | Therapeutic composition for diabetic complications |
GB2198942B (en) * | 1985-11-27 | 1990-07-11 | Senju Pharma Co | Therapeutic composition for diabetic complications |
US5364885A (en) * | 1992-11-13 | 1994-11-15 | Ahluwalia Gurpreet S | Reduction of hair growth |
WO2001019359A2 (en) * | 1999-09-16 | 2001-03-22 | Britannia Pharmaceuticals Limited | Medicaments containing pantothenic acid for the treatment of inflammatory joint disease |
WO2001019359A3 (en) * | 1999-09-16 | 2002-10-03 | Britannia Pharmaceuticals Ltd | Medicaments containing pantothenic acid for the treatment of inflammatory joint disease |
US8614249B2 (en) | 1999-09-16 | 2013-12-24 | Prototype Bioforum Ltd. | Medicaments containing pantothenic acid |
US8906966B2 (en) | 2006-07-13 | 2014-12-09 | Paul Sherwood | Medicaments containing panthenol |
US10004711B2 (en) | 2014-05-08 | 2018-06-26 | Dsm Ip Assets B.V. | Methods and compositions comprising 10-hydroxy-2-decenoic acid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1277132A (en) | Pyridobenzo-diazepine derivatives | |
ES8105746A1 (en) | (N-phosphonoacetyl-L-aspartato) (1,2 diaminocyclohexane) platinum (II) and the sodium, potassium or lithium salts thereof, their preparation and pharmaceutical compositions containing them. | |
GB1145623A (en) | Pharmaceutical composition | |
GB1422193A (en) | Pharmaceutical compositions | |
DE3063525D1 (en) | Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them | |
IL65787A (en) | Antiviral pharmaceutical compositions containing alpha,alpha-dialkyl-adamantylamines | |
PH19980A (en) | Benzenesulfonic esters of 2-uriidophenylthioureas,guanidines and substituted guanidines and pharmaceutical compositions containing them | |
GB1195319A (en) | Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines | |
GB1174988A (en) | Novel Benzylaminoimidazoline Derivatives, the preparation thereof and Compositions containing the same | |
GB943071A (en) | Pharmaceutical compositions having appetite reducing properties | |
GB1442619A (en) | 3-phenoxypropylamine derivatives their preparation and use | |
DE3365954D1 (en) | The use of alpha, alpha-dialkyl adamanthylethylamines to treat measles | |
GB915038A (en) | Pharmaceutical compositions comprising calcium sulphosuccinate | |
GB1287433A (en) | Pharmaceutical compositions | |
SE312632B (en) | ||
GB908634A (en) | Pharmaceutical compositions containing pararosaniline or derivatives thereof | |
GB1056200A (en) | Hypotensive compositions containing hydrochlorothiazide | |
GB1417323A (en) | Physiologically active xanthine compounds and compositions containing them | |
GB1530166A (en) | Adenine derivatives | |
GB1422745A (en) | Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same | |
GB879882A (en) | Pharmaceutical preparations containing 6-chloro-7-sulphamyl-3:4-dihydro-1:2:4-benzothiadiazine-1:1-dioxide | |
GB1127748A (en) | Pharmaceutical compositions for use in the treatment of disturbances due to luteinic deficiency | |
GB926784A (en) | 2-(4-methylpiperazino)-ethyl-guanidine and process for its manufacture | |
GB1072344A (en) | Medicated poultry composition | |
FR937028A (en) | Alkaline detergent containing active oxygen |